PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study: Some pancreatic cancer treatments may be going after the wrong targets

Researchers find that eliminating scar tissue, inflammation may make tumors more deadly

2014-05-22
(Press-News.org) ANN ARBOR, Mich. — New research represents a significant change in the understanding of how pancreatic cancer grows – and how it might be defeated.

Unlike other types of cancer, pancreatic cancer produces a lot of scar tissue and inflammation. For years, researchers believed that this scar tissue, called desmoplasia, helped the tumor grow, and they've designed treatments to attack this.

But new research led by Andrew D. Rhim, M.D., from the University of Michigan Comprehensive Cancer Center, finds that when you eliminate desmoplasia, tumors grow even more quickly and aggressively. In the study, mice in which the desmoplasia was eliminated developed tumors earlier and died sooner.

"This flies in the face of 10 years of research," says Rhim, assistant professor of gastroenterology at the U-M Medical School. "It turns out that desmoplasia is a lot more complex than previously thought. Components of this complex scar tissue may be the body's natural defense against this cancer, acting as a barrier or fence to constrain cancer cells from growing and spreading. Researchers who have been trying to target desmoplasia to kill tumors may need to reevaluate their approach."

Several drugs targeting desmoplasia are in clinical trials and one was recently stopped early because of poor results. "Our study explains why this didn't work," Rhim says.

The researchers were able to arrive at this surprising conclusion by using a better mouse model. Previous models have used mice with compromised immune systems injected with human pancreatic cancer cells, producing tumors that don't closely resemble human pancreatic cancer. The current model utilizes mice that are genetically engineered to express the two most common genetic mutations seen in pancreatic cancer. The mice developed cancer spontaneously, and the cancer closely resembled human pancreatic cancer.

Results of the study appear in Cancer Cell. The work represents a collaboration among teams at the University of Pennsylvania, Columbia University, Johns Hopkins University, Memorial Sloan Kettering Cancer Center and Mayo Clinic.

Using genetically engineered mice, the researchers blocked desmoplasia by knocking down the signaling pathway that produces it. They discovered that desmoplasia prevents the formation of blood vessels that fuel the tumor. When it's suppressed, the blood vessels multiply, giving the cancer cells the fuel to grow. The researchers next wondered: What if you then target blood vessels with treatment?

What they found in this study was that a drug designed to attack blood vessels, called an angiogenesis inhibitor, significantly improved overall survival in the mice who had desmoplasia blocked. Angiogenesis inhibitors already exist on the market with approval from the U.S. Food and Drug Administration.

Another key finding of the study is that eliminating desmoplasia created tumors that resembled undifferentiated pancreatic cancer in humans. Undifferentiated tumors lack desmoplasia, have abundant blood vessels and grow and spread quickly. About 10 percent of pancreatic cancers in patients are undifferentiated.

This suggests that angiogenesis inhibitors may be effective in patients with undifferentiated tumors.

This study suggests that patients with highly aggressive, undifferentiated pancreatic cancer may be good candidates for treatment with an angiogenesis inhibitor, a drug that is already approved by the U.S. Food and Drug Administration for other cancers. Researchers are moving toward developing a clinical trial. Plans for such an approach are currently underway.

INFORMATION: Note for patients: There is currently not a clinical trial testing an anti-angiogenesis inhibitor in undifferentiated pancreatic cancer. To learn about pancreatic cancer clinical trials currently available at U-M, call the Cancer AnswerLine at 800-865-1125.

Additional authors: Paul E. Oberstein, Dafydd H. Thomas, Carmine F. Palermo, Steve A. Sastra, Claudia P. Becerra, Ian W. Tattersall, C. Benedikt Westphalen, Jan Kitajewski, Ken Olive, from Columbia University Medical Center; Emily T. Mirek, Erin N. Dekleva, Ben Stanger, from University of Pennsylvania; Tyler Saunders, Christine Iacobuzzio-Donahue from Johns Hopkins University; Maite G. Fernandez-Barrena, Martin E. Fernandez-Zapico from Mayo Clinic

Funding: National Institutes of Health grants DK088945, CA177857, DK034933, CA046952, T32CA009503, CA136526, CA157980, CA169123, DK083355, DK083111, P30DK050306, P30CA013696, S10RR025686; American Gastroenterological Association/Foundation for Digestive Health and Nutrition; Bernard L. Schwartz Designated Research Award in Pancreatic Cancer

Disclosure: None

Reference: Cancer Cell, doi:10.1016/j.ccr.2014.04.021

Resources: U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, http://www.mcancer.org
Clinical trials at U-M, http://www.mcancer.org/clinicaltrials
mCancerTalk blog, http://uofmhealthblogs.org/cancer


ELSE PRESS RELEASES FROM THIS DATE:

'I can' mentality goes long way after childbirth

2014-05-22
The way a woman feels about tackling everyday physical activities, including exercise, may be a predictor of how much weight she'll retain years after childbirth says a Michigan State University professor. James Pivarnik, a professor of kinesiology and epidemiology at MSU, co-led a study that followed 56 women during pregnancy and measured their physical activity levels, along with barriers to exercise and the ability to overcome them. Six years later, the research team followed up with more than half of the participants and found that the women who considered themselves ...

What is being said in the media and academic literature about neurostimulation?

2014-05-22
Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed. TDCS is a non-invasive form of neurostimulation, in which constant, low current is delivered directly to areas of the brain using small electrodes. Originally ...

EuroPCR 2014 examines whether science translates into practice with new session format

2014-05-22
22 May 2014, Paris, France: The value of analysing published clinical trials and the benefit of informed discussion were highlighted yesterday when the ACCOAST trial data were discussed in a new session format—Will this trial change my practice?— at EuroPCR 2014. ACCOAST trial results demonstrate that pre-treatment with prasugrel in NSTEMI patients undergoing percutaneous coronary intervention (PCI) is inferior to treatment with the drug after angiography. Several other trials are also being scrutinised in the same format, which ends with a discussion with the audience ...

New details on microtubules and how the anti-cancer drug Taxol works

New details on microtubules and how the anti-cancer drug Taxol works
2014-05-22
A pathway to the design of even more effective versions of the powerful anti-cancer drug Taxol has been opened with the most detailed look ever at the assembly and disassembly of microtubules, tiny fibers of tubulin protein that form the cytoskeletons of living cells and play a crucial role in mitosis. Through a combination of high-resolution cryo-electron microscopy (cryo-EM) and new methodology for image analysis and structure interpretation, researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have produced ...

Which way is up?

Which way is up?
2014-05-22
What do sled dogs and cell clusters have in common? According to research by UC Santa Barbara's Denise Montell, they both travel in groups and need a leader to make sure they all follow in the same direction. Montell, Duggan Professor of Molecular Cellular and Developmental Biology, and colleagues worked on three independent projects involving E-cadherin, a protein found in epithelial cells throughout the body. The researchers used fruit-fly ovaries to uncover the role played by E-cadherin in collective cell migration. Their findings are reported today in the journal ...

Eumelanin's secrets

2014-05-22
CAMBRIDGE, Mass-- Melanin — and specifically, the form called eumelanin — is the primary pigment that gives humans the coloring of their skin, hair, and eyes. It protects the body from the hazards of ultraviolet and other radiation that can damage cells and lead to skin cancer, but the exact reason why the compound is so effective at blocking such a broad spectrum of sunlight has remained something of a mystery. Now researchers at MIT and other institutions have solved that mystery, potentially opening the way for the development of synthetic materials that could have ...

US obesity epidemic making all segments of the nation fatter, study finds

2014-05-22
The nation's obesity epidemic is striking all groups of Americans, affecting those with more education and those with less education, as well as all ethnic groups, according to a new analysis that challenges prevailing assumptions about the reasons why the nation is getting heavier. While some differences in weight are evident between groups based on race and education levels, all Americans have been getting fatter at about the same rate for the past 25 years, even as the nation saw increases in leisure time, increased availability of fruit and vegetables, and increases ...

Being Sardinian puts a smile on the face of the elderly

2014-05-22
Residents of the Italian island of Sardinia are known for their longevity. Now, a new study also shows that elderly Sardinians are less depressed and generally are in a better mental frame of mind than peers living elsewhere. The study, led by Maria Chiara Fastame and Maria Pietronilla Penna of the University of Cagliari in Italy and Paul Hitchcott from the Southampton Solent University in UK, is published in Springer's journal Applied Research in Quality of Life. Various tests to measure the mental state and capacity of elderly people were performed on 191 cognitively ...

Gene therapy extends survival in an animal model of spinal muscular atrophy

Gene therapy extends survival in an animal model of spinal muscular atrophy
2014-05-22
New Rochelle, NY, May 22, 2014—To make up for insufficient amounts of SMN protein, the cause of the inherited neuromuscular disease spinal muscular atrophy (SMA), researchers have successfully delivered a replacement SMN1 gene directly to the spinal cords of animal models of SMA. A new study demonstrating that enough copies of the SMN1 gene can be delivered to the spinal cord motor neurons to extend the survival of the treated animals is published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the ...

JILA study finds crowding has big effects on biomolecules

JILA study finds crowding has big effects on biomolecules
2014-05-22
Crowding has notoriously negative effects at large size scales, blamed for everything from human disease and depression to community resource shortages. But relatively little is known about the influence of crowding at the cellular level. A new JILA study shows that a crowded environment has dramatic effects on individual biomolecules. In the first data on the underlying dynamics (or kinetics)of crowded single biomolecules , reported in Proceedings of the National Academy of Sciences,* JILA researchers found that crowding leads to a 35-fold increase in the folding rate ...

LAST 30 PRESS RELEASES:

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

Four-day school week may not be best for students, review finds

Using music to explore the dynamics of emotions

How the brain supports social processing as people age

Túngara frog tadpoles that grew up in the city developed faster but ended up being smaller

Where there’s fire, there’s smoke

UCLA researchers uncover key mechanism of brain repair in vascular dementia, revealing promising therapeutic target

Why Human empathy still matters in the age of AI

COVID-19 and cognitive change in a community-based cohort

Intent to test for COVID-19 in the postpandemic era

Landmark study investigates potential of Ambroxol, a cough medicine, to slow Parkinson’s-related dementia

Finding suggests treatment approach for autoimmune diseases

A new “link” to triple-negative breast cancer

[Press-News.org] Study: Some pancreatic cancer treatments may be going after the wrong targets
Researchers find that eliminating scar tissue, inflammation may make tumors more deadly